Business News

Basilea and Roche Partner to Test Bladder Cancer Combination

Basel, Switzerland, January 24, 2019 – Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it entered into a collaboration with Roche (SIX: RO, ROG) to explore a combination of Basilea’s derazantinib and Roche’s PD-L1-blocking immune-checkpoint inhibitor atezolizumab (Tecentriq®) in patients with urothelial cancer. Basilea expects to start a biomarker-driven multi-cohort phase …

Read More »

Alnylam and CAMP4 Therapeutics Enter Rare Disease Research Collaboration

CAMBRIDGE, Mass.–(BUSINESS WIRE)–CAMP4 Therapeutics today announced a research collaboration with Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) focused on identifying new druggable targets to address an undisclosed rare disease of the liver with a significant unmet need. The collaboration brings together CAMP4’s expertise in rapidly pinpointing signaling targets that control the expression …

Read More »

BioNTech to Acquire Antibody Generation Unit of MAB Discovery

MAINZ, Germany & MUNICH–(BUSINESS WIRE)–BioNTech AG, a rapidly growing biotechnology company developing precise and individualized immunotherapies for the treatment of cancer and the prevention of infectious diseases, and MAB Discovery GmbH, a unique player in the generation and development of sophisticated and therapeutically relevant monoclonal antibodies (mAbs), today announced that …

Read More »

CRISPR Therapeutics and ProBioGen Enter Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies

CAMBRIDGE, Mass. and BOSTON and BERLIN, Jan. 22, 2019 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and ProBioGen, a premier German service and technology provider, today announced a multi-year research collaboration focused on the development of novel in vivo delivery modalities for …

Read More »

CVS Health Reaches Pharmacy Benefits Management System Deal with Walmart After Impasse

WOONSOCKET, R.I. and BENTONVILLE, Ark., Jan. 18, 2019 /PRNewswire/ — CVS Health (NYSE: CVS) and Walmart (NYSE: WMT) today announced the companies have reached a multi-year agreement on terms under which Walmart will continue participating in the CVS Caremark pharmacy benefit management (PBM) commercial and Managed Medicaid retail pharmacy networks. The companies are not …

Read More »

Obsidian Therapeutics and Celgene Collaborate to Develop Novel Cell Therapies that Utilize Obsidian’s Destabilizing Domain Technology

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Obsidian Therapeutics, a biotechnology company developing cell therapies with pharmacologic operating systems, today announced a strategic collaboration with Celgene Corporation (NASDAQ: CELG) for the discovery and development of novel, regulated cell therapies that utilize Obsidian’s Destabilizing Domain (DD) technology. Specifically, the collaboration is based on Obsidian’s DD technology for …

Read More »

AMAG Pharmaceuticals Completes Acquisition of Perosphere Pharmaceuticals

WALTHAM, Mass., Jan. 17, 2019 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that it has completed the previously announced acquisition of Perosphere Pharmaceuticals Inc., a private biopharmaceutical company. Through this acquisition, AMAG adds ciraparantag to its development portfolio. Ciraparantag is in development as a single dose, ready-to-use solution …

Read More »

Spectrum Pharmaceuticals Sells Marketed Portfolio to Acrotech Biopharma to Focus on New and Innovative Cancer Therapies

HENDERSON, Nev.–(BUSINESS WIRE)–Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI) announced today that it has entered into a definitive agreement to sell its portfolio of seven FDA-approved hematology/oncology products to Acrotech Biopharma L.L.C. Acrotech Biopharma is a New Jersey-based wholly-owned subsidiary of Aurobindo Pharma USA Inc. “This divestiture marks a major strategic shift …

Read More »

Abbott to Acquire Mitral Valve Device Maker Cephea Valve Technologies

ABBOTT PARK, Ill., Jan. 16, 2019 /PRNewswire/ — Abbott (NYSE: ABT) announced today that it has exercised its option to purchase Cephea Valve Technologies, Inc., a privately held medical device company developing a less-invasive heart valve replacement technology for people with mitral valve disease. Financial terms were not disclosed. Abbott provided capital and secured …

Read More »

ZappRx and Bayer Partner to Improve Access to Specialty Medications

BOSTON–(BUSINESS WIRE)–ZappRx, a digital health company that streamlines the complex processes associated with prescribing specialty medications, announced an agreement with Bayer to provide a more efficient approach to the accessing of specialty medications and associated support programs. ZappRx will support patients living with two specific types of Pulmonary Hypertension (PH) and patients …

Read More »